Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence

Giuseppe Bogina, Gianluigi Lunardi, Francesca Coati, Giuseppe Zamboni, Stefania Gori, Laura Bortesi, Marcella Marconi, Paola Agnese Cassandrini, Monica Turazza, Laura Cortesi, Elisabetta DeMatteis, Guido Ficarra, Toni Ibrahim, Patrizia Serra, Laura Medri, Sara Giraudi, Matteo Lambertini, Franca Carli, Jennifer Foglietta, Angelo SidoniMartina Nunzi, Corrado Ficorella, Maria Rosaria Diadema, Lucia Del Mastro

Research output: Contribution to journalArticle

Abstract

Aims and background: The aim of this retrospective multicenter study was to evaluate the impact of progesterone receptor (PgR) loss on locoregional recurrence in patients with estrogen receptor (ER)-positive primary breast cancer and ER-positive locoregional recurrence. Patients and methods: Eight Italian oncology centers collected data from consecutive patients with ER-positive breast cancer and a subsequent ER-positive locoregional recurrence. Results: Data were available for 265 patients diagnosed with breast cancer between 1990 and 2009. Median metastasis-free survival was 111 months in patients with PgR-positive primary tumors and locoregional recurrence (PgRpos), 38 months in patients with PgR-negative primary tumors and locoregional recurrence (PgRneg), and 63 months in patients with PgR-positive primary tumors and PgR-negative locoregional recurrence (PgRloss). In multivariate analysis, PgR status was independently associated with metastasis-free survival, with a hazard ratio of 2.84 (95% CI 1.34-6.00) for PgRneg compared with PgRpos, and 2.93 (95% CI: 1.51-5.70) for PgRloss compared with PgRpos. Conclusions: PgR absence was found to be a negative prognostic factor in breast cancer patients with ER-positive locoregional recurrence. Thus, PgR status could be a biological marker in ER-positive recurrent breast cancer.

Original languageEnglish
Pages (from-to)398-403
Number of pages6
JournalTumori
Volume101
Issue number4
DOIs
Publication statusPublished - Jul 1 2015

    Fingerprint

Keywords

  • Breast cancer
  • Locoregional recurrence
  • Metastasis
  • Progesterone receptor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Bogina, G., Lunardi, G., Coati, F., Zamboni, G., Gori, S., Bortesi, L., Marconi, M., Cassandrini, P. A., Turazza, M., Cortesi, L., DeMatteis, E., Ficarra, G., Ibrahim, T., Serra, P., Medri, L., Giraudi, S., Lambertini, M., Carli, F., Foglietta, J., ... Del Mastro, L. (2015). Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence. Tumori, 101(4), 398-403. https://doi.org/10.5301/tj.5000323